Dr. Stephen Freedman is a Professor of Pediatrics and Emergency Medicine at the University of Calgary. He completed his residency at The Hospital for Sick Children (Toronto) and a pediatric emergency medicine fellowship at Children’s Memorial Hospital (Chicago). He obtained a Master’s of Science in Clinical Investigation at Northwestern University (Chicago). He currently serves as the Alberta Children’s Hospital Foundation Professor in Child Health and Wellness and the Associate Dean, Clinical Trials, University of Calgary. His research focuses on applying clinical research to improve outcomes in children seeking emergency department care. His focus is on the use of innovative, multidisciplinary approaches to solve complex problems. He has published over 280 peer-reviewed manuscripts and is the principal investigator on numerous multicentre clinical trials with funding support from CIHR and the NIH. Most recently, he received PHAC funding to lead a national pediatric hospital respiratory virus surveillance network and joint NIH-CIHR funding to evaluate an intervention to prevent progression of disease in children infected with Shiga toxin producing E. coli.
In this week's core session of Grand Rounds, he will focus on providing a state-of-the art overview of the use of ondansetron in children with acute gastroenteritis—associated vomiting as well as sharing novel insights related to the care of children with Shiga toxin-Producing Escherichia coli (STEC) infection.